ISLET Act Increase Support for Life-saving Endocrine Transplantation...
To regulate human cadaveric islets for transplantation as organs.
HB8018, also known as the ISLET Act, aims to establish regulations for the use of human cadaveric islets in transplantation, treating them as organs. This bill seeks to ensure that islets, which are small clusters of cells in the pancreas that produce insulin, are managed and transplanted in a safe and effective manner, potentially saving lives of those suffering from certain endocrine disorders.
The proposed regulations would affect medical professionals, patients needing islet transplants, and regulatory bodies overseeing medical practices. By setting clear guidelines for the use of islets, the bill could improve the success rates of transplants and ensure consistent, high-quality medical practices across the country.
As of March 19, 2026, HB8018 has been introduced in the House and referred to the House Committee on Energy and Commerce for further review. This marks the first step in the legislative process, and the bill is now under consideration by the committee.
